Swiss National Bank Boosts Stake in Teladoc Health Inc (NYSE:TDOC)

Swiss National Bank lifted its stake in shares of Teladoc Health Inc (NYSE:TDOC) by 1.8% in the first quarter, HoldingsChannel.com reports. The fund owned 133,400 shares of the health services provider’s stock after acquiring an additional 2,400 shares during the quarter. Swiss National Bank’s holdings in Teladoc Health were worth $20,678,000 at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in the stock. Total Clarity Wealth Management Inc. bought a new position in Teladoc Health in the fourth quarter valued at $25,000. Tower Research Capital LLC TRC bought a new position in shares of Teladoc Health during the 4th quarter valued at about $28,000. PrairieView Partners LLC purchased a new position in shares of Teladoc Health during the 1st quarter valued at about $31,000. Great Diamond Partners LLC purchased a new position in shares of Teladoc Health during the 4th quarter valued at about $33,000. Finally, Citizens Financial Group Inc RI bought a new stake in Teladoc Health in the 4th quarter worth approximately $34,000. Institutional investors own 98.08% of the company’s stock.

In other news, CEO Jason N. Gorevic sold 40,000 shares of the company’s stock in a transaction that occurred on Tuesday, May 5th. The shares were sold at an average price of $170.26, for a total value of $6,810,400.00. Following the transaction, the chief executive officer now owns 711,283 shares in the company, valued at $121,103,043.58. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Adam C. Vandervoort sold 22,516 shares of the stock in a transaction that occurred on Thursday, April 16th. The shares were sold at an average price of $168.83, for a total transaction of $3,801,376.28. Following the sale, the insider now owns 10,824 shares in the company, valued at approximately $1,827,415.92. The disclosure for this sale can be found here. In the last ninety days, insiders sold 208,252 shares of company stock valued at $35,286,838. 3.42% of the stock is owned by insiders.

Shares of NYSE TDOC opened at $174.18 on Monday. The company has a debt-to-equity ratio of 0.45, a quick ratio of 6.14 and a current ratio of 6.14. The company has a 50 day simple moving average of $171.10 and a two-hundred day simple moving average of $118.55. Teladoc Health Inc has a fifty-two week low of $53.46 and a fifty-two week high of $203.85. The company has a market capitalization of $12.97 billion, a price-to-earnings ratio of -129.02 and a beta of 0.44.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings data on Wednesday, April 29th. The health services provider reported ($0.40) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.35) by ($0.05). Teladoc Health had a negative net margin of 16.24% and a negative return on equity of 10.60%. The company had revenue of $180.80 million for the quarter, compared to the consensus estimate of $180.64 million. During the same period last year, the business earned ($0.43) EPS. The firm’s quarterly revenue was up 40.6% on a year-over-year basis. On average, analysts forecast that Teladoc Health Inc will post -1.12 earnings per share for the current fiscal year.

A number of brokerages have recently issued reports on TDOC. Oppenheimer initiated coverage on shares of Teladoc Health in a research note on Friday, February 14th. They issued a “buy” rating and a $84.00 price objective for the company. Cantor Fitzgerald raised their price objective on Teladoc Health from $145.00 to $165.00 and gave the company a “neutral” rating in a research note on Thursday, April 30th. UBS Group increased their target price on Teladoc Health from $119.00 to $185.00 and gave the company a “neutral” rating in a report on Thursday, April 30th. Craig Hallum lifted their price target on Teladoc Health from $140.00 to $150.00 and gave the stock a “hold” rating in a research note on Thursday, April 30th. Finally, Barclays reissued a “hold” rating and set a $180.00 price objective (up previously from $140.00) on shares of Teladoc Health in a research note on Thursday, April 30th. Fifteen equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. The stock presently has an average rating of “Hold” and an average price target of $162.54.

About Teladoc Health

Teladoc Health, Inc provides telehealth services. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.

Featured Story: What causes a recession?

Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health Inc (NYSE:TDOC).